$GRYP
Gryphon Digital Mining Inc Stock $gryp

$gryp Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000121390022026598 Filed on May 16, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q1
Revenue	$6.086M	$6.951M	$4.014M
YoY Change	24.03%	73.16%	30.73%
Cost Of Revenue	$1.836M	$2.204M	$1.454M
YoY Change	-4.1%	51.54%	4.15%
Gross Profit	$4.250M	$4.747M	$2.560M
YoY Change	42.02%	85.45%	52.89%
Gross Profit Margin	69.83%	68.3%	63.77%
Selling, General & Admin	$5.604M	$5.807M	$3.589M
YoY Change	-9.64%	61.79%	-36.8%
% of Gross Profit	131.87%	122.32%	140.2%
Research & Development	$1.761M	$2.105M	$1.424M
YoY Change	15.33%	47.84%	62.79%
% of Gross Profit	41.45%	44.35%	55.63%
Depreciation & Amortization	$1.983M	$1.993M	$1.053M
YoY Change	50.56%	89.33%	37183.36%
% of Gross Profit	46.66%	41.99%	41.13%
Operating Expenses	$33.47M	$25.38M	$6.066M
YoY Change	270.11%	318.47%	-7.43%
Operating Profit	-$29.22M	-$20.64M	-$3.506M
YoY Change	382.91%	488.61%	-28.14%
Interest Expense	-$213.0K	-$740.00	$776.2K
YoY Change	30.56%	-100.1%
% of Operating Profit
Other Income/Expense, Net	-$473.1K	-$1.416M	-$2.942M
YoY Change	924.95%	-51.87%	-1188.23%
Pretax Income	-$29.69M	-$22.05M	-$6.448M
YoY Change	387.01%	242.02%	39.91%
Income Tax	-$128.0K	-$99.44K	$6.270K
% Of Pretax Income
Net Earnings	-$29.57M	-$21.95M	-$6.458M
YoY Change	384.27%	239.95%	43.27%
Net Earnings / Revenue	-485.81%	-315.83%	-160.88%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.83	-$694.6K	-$290.9K
COMMON SHARES
Basic Shares Outstanding	34.96M shares	32.05M shares
Diluted Shares Outstanding	35.48M shares	1.580M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.125M	$9.688M	$15.43M
YoY Change	-56.49%	-37.22%	7.83%
Cash & Equivalents	$5.125M	$9.688M	$15.43M
Short-Term Investments
Other Short-Term Assets	$1.431M	$2.453M	$2.040M
YoY Change	-46.47%	20.23%	-9.73%
Inventory
Prepaid Expenses	$2.155M	$2.492M	$2.096M
Receivables	$1.882M	$2.579M	$1.887M
Other Receivables	$733.1K	$547.7K	$550.0K
Total Short-Term Assets	$9.170M	$15.27M	$19.91M
YoY Change	-44.35%	-23.32%	11.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$143.0K	$159.2K	$1.140M
YoY Change	168.07%	-86.03%	1528.13%
Goodwill	$9.080M	$29.96M	$41.87M
YoY Change	-80.59%	-28.44%
Intangibles
YoY Change
Long-Term Investments	$226.1K	$226.1K	$230.0K
YoY Change	0.0%	-1.7%	-8.0%
Other Assets	$9.700K	$9.700K
YoY Change
Total Long-Term Assets	$34.00M	$59.08M	$54.42M
YoY Change	-43.39%	8.56%	132.07%
TOTAL ASSETS
Total Short-Term Assets	$9.170M	$15.27M	$19.91M
Total Long-Term Assets	$34.00M	$59.08M	$54.42M
Total Assets	$43.17M	$74.35M	$74.33M
YoY Change	-43.6%	0.02%	79.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.793M	$3.066M	$495.8K
YoY Change	236.72%	518.34%	-87.7%
Accrued Expenses	$2.337M	$3.208M	$2.560M
YoY Change	-34.27%	25.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$6.600M	$13.20M	$8.780M
YoY Change	-7.77%	50.34%
Total Short-Term Liabilities	$22.37M	$30.38M	$13.44M
YoY Change	67.26%	126.11%	181.66%
LONG-TERM LIABILITIES
Long-Term Debt	$6.788M	$2.137M	$1.130M
YoY Change	465.36%	89.12%
Other Long-Term Liabilities	$602.1K	$486.2K
YoY Change
Total Long-Term Liabilities	$6.788M	$2.137M	$1.130M
YoY Change	465.36%	89.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.37M	$30.38M	$13.44M
Total Long-Term Liabilities	$6.788M	$2.137M	$1.130M
Total Liabilities	$30.22M	$33.57M	$14.56M
YoY Change	107.4%	130.49%	52.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$140.0M	-$110.5M	-$63.64M
YoY Change	100.78%	73.58%
Common Stock	$150.4M	$148.8M	$110.9M
YoY Change	21.46%	34.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.95M	$40.78M	$59.77M
YoY Change
Total Liabilities & Shareholders Equity	$43.17M	$74.35M	$74.33M
YoY Change	-43.6%	0.02%	79.76%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$29.57M	-$21.95M	-$6.458M
YoY Change	384.27%	239.95%	43.27%
Depreciation, Depletion And Amortization	$1.983M	$1.993M	$1.053M
YoY Change	50.56%	89.33%	37183.36%
Cash From Operating Activities	-$3.602M	-$3.585M	-$1.374M
YoY Change	53.59%	160.98%	-69.61%
INVESTING ACTIVITIES
Capital Expenditures	-$1.117M	-$647.0K	-$700.0K
YoY Change	-14.34%	-7.57%
Acquisitions
YoY Change
Other Investing Activities	$400.0K		$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$717.5K	-$647.0K	-$704.6K
YoY Change	-45.0%	-8.18%	26.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-761.4K	-$5.615K	-$333.8K
YoY Change	19675.84%	-98.32%
NET CHANGE
Cash From Operating Activities	-3.602M	-$3.585M	-$1.374M
Cash From Investing Activities	-717.5K	-$647.0K	-$704.6K
Cash From Financing Activities	-761.4K	-$5.615K	-$333.8K
Net Change In Cash	-5.081M	-$4.247M	-$2.414M
YoY Change	39.06%	75.92%	-46.01%
FREE CASH FLOW
Cash From Operating Activities	-$3.602M	-$3.585M	-$1.374M
Capital Expenditures	-$1.117M	-$647.0K	-$700.0K
Free Cash Flow	-$2.485M	-$2.938M	-$673.8K
YoY Change	138.77%	336.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001755953
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Akerna Corp.
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Entity File Number EntityFileNumber	001-39096
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2242651
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1550 Larimer Street
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	#246
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80202
CY2022Q1	dei	City Area Code CityAreaCode	(888)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	932-6537
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	KERN
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34964678	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9687690	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13934265	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	508261	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	508261	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1403774	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2492089	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2383764	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	15267227	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	18230064	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159159	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	153151	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	226101	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	226101	USD
CY2022Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	8012387	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7311676	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20708046	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21609794	USD
CY2022Q1	us-gaap	Goodwill Goodwill	29964160	USD
CY2021Q4	us-gaap	Goodwill Goodwill	46942681	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9700	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9700	USD
CY2022Q1	us-gaap	Assets Assets	74346780	USD
CY2021Q4	us-gaap	Assets Assets	94483167	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6063520	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6300000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6300000	USD
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3369631	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3543819	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	13200000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13200000	USD
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	45127	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	63178	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30378099	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29170517	USD
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	486201	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	582676	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2137000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4105000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	565184	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	675291	USD
CY2022Q1	us-gaap	Liabilities Liabilities	33566484	USD
CY2021Q4	us-gaap	Liabilities Liabilities	34533484	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2022Q1	kern	Exchangable Preferred Stock ExchangablePreferredStock	2347418	USD
CY2021Q4	kern	Exchangable Preferred Stock ExchangablePreferredStock	2366038	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34175088	shares
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-22052337	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6447651	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	1454167	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	4747170	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	2559857	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2105361	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1424100	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3236113	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1735915	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2570432	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1852962	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1993391	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1052883	USD
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	15478521	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31001884	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31001884	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3417	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3100	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	148761867	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	146027258	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	128723	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	61523	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110461129	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88508236	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	40780296	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	59949683	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74346780	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	94483167	USD
CY2022Q1	us-gaap	Revenues Revenues	6950841	USD
CY2021Q1	us-gaap	Revenues Revenues	4014024	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2203671	USD
CY2021Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	25383818	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	6065860	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-20636648	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3506003	USD
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-740	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-774380	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1433000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1991272	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18051	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-175996	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1415689	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2941648	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-99444	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6270	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3782	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21952893	USD
CY2022Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31605783	shares
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22209072	shares
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	57222620	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		USD
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	8467500	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	333847	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	503379	USD
CY2021Q1	kern	Stock Issued During Period Value Settlement Of Liabilities StockIssuedDuringPeriodValueSettlementOfLiabilities	377325	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	503379	USD
CY2022Q1	kern	Amortization Of Deferred Contract Costs AmortizationOfDeferredContractCosts	113251	USD
CY2021Q1	kern	Amortization Of Deferred Contract Costs AmortizationOfDeferredContractCosts	118519	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21952893	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-6457703	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-33800	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-230	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	101000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-13000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21885693	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6470933	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	59949683	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		USD
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3300000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5615	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	940000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	316855	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		USD
CY2022Q1	kern	Stock Issued During Period Value Settlement Of Liabilities StockIssuedDuringPeriodValueSettlementOfLiabilities	45066	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-33800	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	101000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21952893	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	40780296	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-230	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-13000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	59766044	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-21952893	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-6457703	USD
CY2022Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments		USD
CY2021Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	3782	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	174794	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10516	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	304237	USD
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest		USD
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	769773	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1993391	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1052882	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5596	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	18801	USD
CY2022Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	15478521	USD
CY2021Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1433000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1991272	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18051	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-175996	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1335939	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177832	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-178869	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-236339	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	445969	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	152455	USD
CY2022Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-110107	USD
CY2021Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability		USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-296032	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	286637	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3585394	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1373818	USD
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	647022	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	704637	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-647022	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-704637	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5615	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	333847	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5615	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-333847	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-8544	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1579	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4246575	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2413881	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14442526	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18340640	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10195951	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15926759	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet		USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5210	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		USD
CY2022Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3300000	USD
CY2021Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	8467292	USD
CY2022Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	18620	USD
CY2021Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	7803475	USD
CY2022Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	45065	USD
CY2021Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	377325	USD
CY2022Q1	kern	Stock Based Compensation Capitalized As Software Development StockBasedCompensationCapitalizedAsSoftwareDevelopment	12618	USD
CY2021Q1	kern	Stock Based Compensation Capitalized As Software Development StockBasedCompensationCapitalizedAsSoftwareDevelopment		USD
CY2022Q1	kern	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits	4	USD
CY2021Q1	kern	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		USD
CY2022Q1	kern	Capitalized Software Included In Accrued Expenses CapitalizedSoftwareIncludedInAccruedExpenses	1114108	USD
CY2021Q1	kern	Capitalized Software Included In Accrued Expenses CapitalizedSoftwareIncludedInAccruedExpenses		USD
CY2022Q1	kern	Fixed Asset Purchases Accrued Or In Accounts Payable FixedAssetPurchasesAccruedOrInAccountsPayable	24614	USD
CY2021Q1	kern	Fixed Asset Purchases Accrued Or In Accounts Payable FixedAssetPurchasesAccruedOrInAccountsPayable		USD
CY2022Q1	kern	Shares Returned In Connection With365 Cannabis Acquisition SharesReturnedInConnectionWith365CannabisAcquisition	940000	USD
CY2021Q1	kern	Shares Returned In Connection With365 Cannabis Acquisition SharesReturnedInConnectionWith365CannabisAcquisition		USD
CY2022Q1	kern	Cannabis Working Capital Funds Released From Accrued Expenses CannabisWorkingCapitalFundsReleasedFromAccruedExpenses	160000	USD
CY2021Q1	kern	Cannabis Working Capital Funds Released From Accrued Expenses CannabisWorkingCapitalFundsReleasedFromAccruedExpenses		USD
CY2022Q1	kern	Cannabis Working Capital Adjustment Funds Recorded In Other Receivables CannabisWorkingCapitalAdjustmentFundsRecordedInOtherReceivables	400000	USD
CY2021Q1	kern	Cannabis Working Capital Adjustment Funds Recorded In Other Receivables CannabisWorkingCapitalAdjustmentFundsRecordedInOtherReceivables		USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="border-left: none; border-right: none;"> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business</span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Akerna Corp., herein referred to as we, us, our or Akerna, through our wholly-owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, solo sciences, inc., or Solo, Viridian Sciences Inc., or Viridian, and The NAV People, Inc. d.b.a. 365 Cannabis, or 365 Cannabis, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform®, Trellis®, Ample, Viridian and 365 Cannabis to state-licensed businesses, and our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies. Through Solo, we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with soloTAG™. The integration of MJ Platform® and soloCODE™ results in technology for consumers and brands that brings a consumer-facing mark designed to highlight the authenticity and signify transparency.</span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Our Viridian and 365 Cannabis offerings are considered enterprise offerings and all other solutions are considered non-enterprise offerings that meet the needs of our small and medium business customers.</span><br/></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.2;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness, and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations.</p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 12pt; text-align: justify; line-height: 13pt; margin: 0cm 0cm 0.0001pt;"><b><i><span style="font-size: 10pt; color: #000000;">Going Concern and Management's Liquidity Plans</span></i></b></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; text-align: justify; text-indent: 33.35pt; margin: 0cm 0cm 0.0001pt; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;"><span>In accordance with the Financial Accounting Standards Board’s (“FASB”) standard on going concern, Accounting Standard Update No. 2014-15, or ASU No. 2014-15, the Company assesses going concern uncertainty in its consolidated financial statements to determine if it has sufficient cash, cash equivalents and working capital on hand, including marketable equity securities, and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is referred to as the “look-forward period” as defined by ASU No. 2014-15. As part of this assessment, based on conditions that are known and reasonably knowable to the Company, it will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and its ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, the Company makes certain assumptions around implementing curtailments or delays in the nature and timing of programs and expenditures to the extent The Company deems probable those implementations can be achieved and it has the proper authority to execute them within the look-forward period in accordance with ASU No. 2014-15.<br/></span></span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 12pt; text-align: justify; text-indent: 33.35pt; margin: 0cm 0cm 0.0001pt; line-height: 1.2;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; background-color: #ffffff; display: inline !important; line-height: inherit;"><span><span>The accompanying condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since our inception we have incurred recurring operating losses, used cash from operations, and relied on capital raising transactions to continue ongoing operations. During the three months ended March 31, 2022 and March 31, 2021, we incurred a loss from operations of $20.6 million and $3.5 million, respectively, and used cash in operations of $</span>3.6<span> million and $</span>1.4<span> million, respectively. As of March 31, 2022, a working capital deficit of $</span>15.1<span> million with $</span>9.7<span> million in cash available to fund future operations. </span> </span></span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <div style="font-family: 'times new roman', times; font-size: 10pt;"> </div> <p style="text-indent: 44.4444px; text-align: justify; margin: 0cm 0cm 0.0001pt; line-height: 1.2; font-size: 10pt;"><span><span style="font-size: 13.3333px;"> </span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;">Management’s <span style="line-height: inherit;">plan for the Company to continue as a going concern includes raising additional capital from our ATM program, subject to certain effects on the Senior Convertible Notes should we utilize the program, including resetting the conversion price of the Senior Convertible Notes should we raise more than <span>$5 million</span> under the ATM program and an increase of <span>10%</span> in the amount payable on the monthly installment payments if they are paid in cash and we have used the ATM program in the 12 months prior to the installment date, settling our contingent consideration and Senior Convertible Notes in common stock rather than cash as it comes due, to the extent that this is permissible, and implementing certain cost cutting strategies throughout the organization, while continuing to seek to grow our customer base and realize synergies as we continue to integrate our recent acquisitions. If the Company is unable to raise sufficient additional funds through the ATM Program and make it's convertible debt payments in stock, it will have to develop and implement a plan to extend payables, reduce expenditures (including by laying off employees and reducing or eliminating the funding of certain business units and initiatives of the Company), or scale back our business plan until sufficient additional capital is raised through other equity or debt offerings to support further operations and satisfaction of the debt, and the Company may be subject to additional risks, including retention of key employees. Such offerings may include the issuance of shares of common stock, warrants to purchase common stock, preferred stock, convertible debt or other instruments that may dilute our current stockholders.</span></span><span style="line-height: inherit;"> If we are required to raise additional capital as discussed above and if we cannot timely raise additional funds, we may also be unable to meet the financial covenants of the Senior Convertible Notes, which could result in an event of default under those instruments which could negatively impact the Company. See the risks detailed in our Form 10-K under “Item 1A. Risk Factors – Risks Relating to our Convertible Debt”.</span></span><br/></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 32pt; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. We will require additional financing in the second quarter of </span>2022<span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> to meet our ongoing operational working capital requirements and continue to meet the financial covenants of the Senior Convertible Notes. As noted above, we plan to meet those requirements in part through the use of our ATM Facility, but there are no guarantees that the ATM Facility will permit us to raise sufficient cash to meet our ongoing requirements. We also assume that we will be able to pay our convertible debt in common stock rather than cash, however if at any point our stock price is below $2.00(which it is as of the date hereof), the debt holders may request the payments in cash rather than stock. These factors raise substantial doubt about the Company’s ability to continue as a going concern for </span>one<span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> year from the issuance of the consolidated financial statements. If we are unable to raise sufficient capital we may have to reduce operations which could significantly affect our results of operations. If we fail to meet the financial covenants of the Senior Convertible Notes and cannot obtain a waiver from such provisions or otherwise come to an agreement with the holders of our debt, such holders may declare a default on the debt which could subject our assets to seizure and sale, negatively impacting our business. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary if the Company is unable to continue as a going concern.</span></p> </div>
CY2022Q1	kern	Loss From Operations LossFromOperations	20600000	USD
CY2021Q1	kern	Loss From Operations LossFromOperations	3500000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3600000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1400000	USD
CY2022Q1	kern	Working Capital WorkingCapital	15100000	USD
CY2022Q1	us-gaap	Cash Cash	9.7	USD
CY2021Q4	kern	Percentage Can Be Increased Of Amount Payable On Monthly Installment Payments PercentageCanBeIncreasedOfAmountPayableOnMonthlyInstallmentPayments	0.10	pure
CY2022Q1	us-gaap	Debt Instrument Covenant Compliance DebtInstrumentCovenantCompliance	We also assume that we will be able to pay our convertible debt in common stock rather than cash, however if at any point our stock price is below $2.00(which it is as of the date hereof), the debt holders may request the payments in cash rather than stock.
CY2022Q1	us-gaap	Debt Instrument Convertible Stock Price Trigger DebtInstrumentConvertibleStockPriceTrigger	2
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'times new roman', times;"><b><i><span style="font-size: 10.0pt;">Use of Estimates</span></i></b></span></p> <p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><br/></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to the valuation of acquisition-related assets and liabilities, capitalization of internal costs associated with software development, fair value measurements, impairment assessments, loss contingencies, valuation allowance associated with deferred tax assets, stock based compensation expenses, and useful lives of long-lived intangible assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. </span></span></span></p>
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	600000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000	USD
CY2022Q1	kern	Prepaid Expenses Software And Technology PrepaidExpensesSoftwareAndTechnology	723513	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;">Concentrations of Credit Risk</span></i></b></span></p> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><br/></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. </span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3;"><br/></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span><span style="font-size: 10pt; color: #000000; line-height: inherit;"><span>During the three months ended March 31, 2022 and 2021, one government client accounted for 12<span>% and 12%</span> of total revenues, respectively. <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">As of March 31, 2022, </span>one government client accounted for 19% of net accounts receivable and as of December 31, 2021 two government clients accounted for 34% of net accounts receivable. </span></span></span></p>
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022Q1	us-gaap	Noncurrent Assets NoncurrentAssets	39383	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6951000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4014000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6951000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4014000	USD
CY2022Q1	kern	Unsatisfied Performance Obligations UnsatisfiedPerformanceObligations	15100000	USD
CY2022Q1	kern	Revenueexpectedtoberecognized Revenueexpectedtoberecognized	8400000	USD
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	4126000	USD
CY2022Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	6069000	USD
CY2022Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	6339000	USD
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	3856000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7000000	USD
CY2021Q4	us-gaap	Deferred Income DeferredIncome	2400000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	301	USD
CY2022Q1	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	112	USD
CY2022Q1	kern	Amortized Costs AmortizedCosts	-113	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300	USD
CY2021Q2	kern	Exchangeable Shares ExchangeableShares	1000000	shares
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7407000	USD
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	6574000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1
CY2022Q1	kern	Prepaid Professional Fees PrepaidProfessionalFees	284333	USD
CY2021Q4	kern	Prepaid Professional Fees PrepaidProfessionalFees	546126	USD
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	143355	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	264097	USD
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	254771	USD
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	260899	USD
CY2022Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	547675	USD
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	506984	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	538442	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	117918	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2492089	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2383764	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3065862	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1943457	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	230127	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	319590	USD
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	422580	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	360361	USD
CY2022Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1217392	USD
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1123467	USD
CY2022Q1	kern	Accrued Contractors AccruedContractors	1158447	USD
CY2021Q4	kern	Accrued Contractors AccruedContractors	1288730	USD
CY2022Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1189561	USD
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	681045	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	179372	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	346870	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7463341	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6063520	USD
CY2020Q2	us-gaap	Convertible Debt ConvertibleDebt	17000000	USD
CY2020Q2	kern	Debt Purchase Price DebtPurchasePrice	15000000	USD
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-10-05
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	20000000	USD
CY2021Q4	kern	Debt Purchase Price DebtPurchasePrice	18000000	USD
CY2021Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	17305000	USD
CY2020Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	13398000	USD
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3300000	USD
CY2021Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	7697727	USD
CY2022Q1	kern	Changes In Fair Value Reported In Statements Of Operations ChangesInFairValueReportedInStatementsOfOperations	1433000	USD
CY2021Q1	kern	Changes In Fair Value Reported In Statements Of Operations ChangesInFairValueReportedInStatementsOfOperations	1991272	USD
CY2022Q1	kern	Change In Fair Value Reported In Other Comprehensive Income ChangeInFairValueReportedInOtherComprehensiveIncome	-101000	USD
CY2021Q1	kern	Change In Fair Value Reported In Other Comprehensive Income ChangeInFairValueReportedInOtherComprehensiveIncome	13000	USD
CY2022Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	15337000	USD
CY2022Q1	kern	Equity Instrument Convertible Conversion Ratio EquityInstrumentConvertibleConversionRatio	1	pure
CY2021Q1	kern	Termination Fee TerminationFee	564234	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19125545	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8771020	shares
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	kern	Weighting To The Market Approach WeightingToTheMarketApproach	0.50	pure
CY2022Q1	kern	Weighted To The Income Approach WeightedToTheIncomeApproach	0.50	pure
CY2022Q1	kern	Impairment Expenses ImpairmentExpenses	15500000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.0045	pure
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2022Q1	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	80%

Files In Submission

Name	View Source	Status
0001213900-22-026598-index-headers.html	Edgar Link	pending
0001213900-22-026598-index.html	Edgar Link	pending
0001213900-22-026598.txt	Edgar Link	pending
0001213900-22-026598-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kern-20220331.htm	Edgar Link	pending
kern-20220331.xsd	Edgar Link	pending
kern-20220331_cal.xml	Edgar Link	unprocessable
kern-20220331_def.xml	Edgar Link	unprocessable
kern-20220331_htm.xml	Edgar Link	completed
kern-20220331_lab.xml	Edgar Link	unprocessable
kern-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRYP
Gryphon Digital Mining Inc Stock $gryp

2022 Q2 Form 10-Q Financial Statement

#000121390022026598 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRYP Gryphon Digital Mining Inc Stock $gryp

2022 Q2 Form 10-Q Financial Statement

#000121390022026598 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRYP
Gryphon Digital Mining Inc Stock $gryp